3-[(7-Chloroquinolin-4-yl)amino]propan-1-ol

ID: ALA460418

Cas Number: 60548-22-3

PubChem CID: 370995

Max Phase: Preclinical

Molecular Formula: C12H13ClN2O

Molecular Weight: 236.70

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  OCCCNc1ccnc2cc(Cl)ccc12

Standard InChI:  InChI=1S/C12H13ClN2O/c13-9-2-3-10-11(14-5-1-7-16)4-6-15-12(10)8-9/h2-4,6,8,16H,1,5,7H2,(H,14,15)

Standard InChI Key:  MCVPFDOUKZBWJF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 16 17  0  0  0  0  0  0  0  0999 V2000
   -2.6793    1.3406    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
    3.7510    0.1031    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2503   -1.1344    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8931    0.1031    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5359    0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2503   -0.3094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1786   -0.3094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5359    0.9281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9648    0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9648    0.9281    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1786   -1.1344    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2503    1.3406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5359   -1.5469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6076   -0.3094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3220    0.1031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0365   -0.3094    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 10  1  0
  2 16  1  0
  3  6  1  0
  3 13  2  0
  4  7  1  0
  4 14  1  0
  5  6  2  0
  5  7  1  0
  5  8  1  0
  6  9  1  0
  7 11  2  0
  8 12  2  0
  9 10  2  0
 10 12  1  0
 11 13  1  0
 14 15  1  0
 15 16  1  0
M  END

Associated Targets(Human)

CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
L6 (7924 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Plasmodium falciparum (966862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cruzipain (33337 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Ctsb Cathepsin B (50 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Trypanosoma cruzi (99888 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
rhodesain Rhodesain (1463 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 236.70Molecular Weight (Monoisotopic): 236.0716AlogP: 2.68#Rotatable Bonds: 4
Polar Surface Area: 45.15Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.31CX LogP: 1.58CX LogD: 1.34
Aromatic Rings: 2Heavy Atoms: 16QED Weighted: 0.80Np Likeness Score: -1.14

References

1. de Souza MV, Pais KC, Kaiser CR, Peralta MA, de L Ferreira M, Lourenço MC..  (2009)  Synthesis and in vitro antitubercular activity of a series of quinoline derivatives.,  17  (4): [PMID:19188070] [10.1016/j.bmc.2009.01.013]
2. Tukulula M, Sharma RK, Meurillon M, Mahajan A, Naran K, Warner D, Huang J, Mekonnen B, Chibale K..  (2013)  Synthesis and antiplasmodial and antimycobacterial evaluation of new nitroimidazole and nitroimidazooxazine derivatives.,  (1): [PMID:24900574] [10.1021/ml300362a]
3. Njogu PM, Gut J, Rosenthal PJ, Chibale K..  (2013)  Design, Synthesis, and Antiplasmodial Activity of Hybrid Compounds Based on (2R,3S)-N-Benzoyl-3-phenylisoserine.,  (7): [PMID:24900723] [10.1021/ml400164t]
4. Braga SF, Martins LC, da Silva EB, Sales Júnior PA, Murta SM, Romanha AJ, Soh WT, Brandstetter H, Ferreira RS, de Oliveira RB..  (2017)  Synthesis and biological evaluation of potential inhibitors of the cysteine proteases cruzain and rhodesain designed by molecular simplification.,  25  (6): [PMID:28215783] [10.1016/j.bmc.2017.02.009]
5. Rocha DA, Silva EB, Fortes IS, Lopes MS, Ferreira RS, Andrade SF..  (2018)  Synthesis and structure-activity relationship studies of cruzain and rhodesain inhibitors.,  157  [PMID:30282318] [10.1016/j.ejmech.2018.08.079]

Source